BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peluso S, Antenora A, De Rosa A, Roca A, Maddaluno G, Brescia Morra V, De Michele G. Antiphospholipid-related chorea. Front Neurol 2012;3:150. [PMID: 23097646 DOI: 10.3389/fneur.2012.00150] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Singer HS. Autoantibody-Associated Movement Disorders in Children: Proven and Proposed. Semin Pediatr Neurol 2017;24:168-79. [PMID: 29103424 DOI: 10.1016/j.spen.2017.08.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
2 Xibillé-friedmann D, Pérez-rodríguez M, Carrillo-vázquez S, Álvarez-hernández E, Aceves FJ, Ocampo-torres MC, García-garcía C, García-figueroa JL, Merayo-chalico J, Barrera-vargas A, Portela-hernández M, Sicsik S, Andrade-ortega L, Rosales-don Pablo VM, Martínez A, Prieto-seyffert P, Pérez-cristóbal M, Saavedra MÁ, Castro-colín Z, Ramos A, Huerta-sil G, Hernández-cabrera MF, Jara LJ, Limón-camacho L, Tinajero-nieto L, Barile-fabris LA. Guía de práctica clínica para el manejo del lupus eritematoso sistémico propuesta por el Colegio Mexicano de Reumatología. Reumatología Clínica 2019;15:3-20. [DOI: 10.1016/j.reuma.2018.03.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
3 Freeman H, Patel J, Fernandez D, Sharples P, Ramanan AV. Fitting and flailing: recognition of paediatric antiphospholipid syndrome. Arch Dis Child Educ Pract Ed 2014;99:28-36. [PMID: 24091699 DOI: 10.1136/archdischild-2012-302404] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
4 Safarpour D, Buckingham S, Jabbari B. Chorea associated with high titers of antiphospholipid antibodies in the absence of antiphospholipid antibody syndrome. Tremor Other Hyperkinet Mov (N Y) 2015;5:294. [PMID: 25774325 DOI: 10.7916/D8DB80M9] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Menozzi E, Mulroy E, Akbarian-Tefaghi L, Bhatia KP, Balint B. Movement disorders in systemic autoimmune diseases: Clinical spectrum, ancillary investigations, pathophysiological considerations. Parkinsonism Relat Disord 2021;88:116-28. [PMID: 34092506 DOI: 10.1016/j.parkreldis.2021.05.026] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Yilmaz S, Mink JW. Treatment of Chorea in Childhood. Pediatric Neurology 2020;102:10-9. [DOI: 10.1016/j.pediatrneurol.2019.08.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Menezes R, Pantelyat A, Izbudak I, Birnbaum J. Movement and Other Neurodegenerative Syndromes in Patients with Systemic Rheumatic Diseases: A Case Series of 8 Patients and Review of the Literature. Medicine (Baltimore) 2015;94:e0971. [PMID: 26252269 DOI: 10.1097/MD.0000000000000971] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Dombernowsky NW, Nielsen EN, Law I, Nielsen JE. Beneficial effect of intravenous immunoglobulin treatment in a patient with antiphospholipid syndrome associated chorea. Journal of the Neurological Sciences 2018;390:52-3. [DOI: 10.1016/j.jns.2018.04.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Feinstein E, Walker R. Treatment of Secondary Chorea: A Review of the Current Literature. Tremor Other Hyperkinet Mov (N Y) 2020;10:22. [PMID: 32775036 DOI: 10.5334/tohm.351] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Garone G, Graziola F, Grasso M, Capuano A. Acute Movement Disorders in Childhood. J Clin Med 2021;10:2671. [PMID: 34204464 DOI: 10.3390/jcm10122671] [Reference Citation Analysis]
11 Rege S, Mackworth-young C. Antiphospholipid antibodies as biomarkers in psychiatry: review of psychiatric manifestations in antiphospholipid syndrome. Translational Developmental Psychiatry 2015;3:25452. [DOI: 10.3402/tdp.v3.25452] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
12 Annem C, Furie RA. Antiphospholipid Syndrome: It's Far More Than You Think. J Clin Rheumatol 2017;23:278-84. [PMID: 28742725 DOI: 10.1097/RHU.0000000000000564] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
13 Brogna C, Luigetti M, Norcia G, Scalise R, Ferrantini G, Berti B, Romeo DM, Manna R, Mercuri E, Pane M. Pediatric Motor Inflammatory Neuropathy: The Role of Antiphospholipid Antibodies. Brain Sci 2020;10:E156. [PMID: 32156084 DOI: 10.3390/brainsci10030156] [Reference Citation Analysis]
14 Kyle K, Bordelon Y, Venna N, Linnoila J. Autoimmune and Paraneoplastic Chorea: A Review of the Literature. Front Neurol 2022;13:829076. [DOI: 10.3389/fneur.2022.829076] [Reference Citation Analysis]
15 Talotta R, Atzeni F, Laska MJ. The contribution of HERV-E clone 4-1 and other HERV-E members to the pathogenesis of rheumatic autoimmune diseases. APMIS 2020;128:367-77. [PMID: 32202683 DOI: 10.1111/apm.13039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Man YL, Sanna G. Neuropsychiatric Manifestations of Antiphospholipid Syndrome—A Narrative Review. Brain Sciences 2022;12:91. [DOI: 10.3390/brainsci12010091] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
17 Borisova AB, Lisitsyna TA, Veltishchev DY, Reshetnyak TM, Seravina OF, Kovalevskaya OB, Krasnov VN, Nasonov EL. [Mental disorders and cognitive impairment in patients with antiphospholipid syndrome]. Ter Arkh 2020;92:92-103. [PMID: 32598781 DOI: 10.26442/00403660.2020.05.000625] [Reference Citation Analysis]
18 Brogna C, Mariotti P, Manna R. Conventional and intravenous immunoglobulin therapy in paediatric antiphospholipid antibodies-related chorea. Lupus 2014;23:1449-51. [PMID: 25237169 DOI: 10.1177/0961203314551084] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
19 Mallhi RS, Kushwaha N, Chatterjee T, Philip J. Antiphospholipid syndrome: A diagnostic challenge. Med J Armed Forces India 2016;72:S31-6. [PMID: 28050066 DOI: 10.1016/j.mjafi.2016.05.001] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Miyamae T, Kawabe T. Non-Criteria Manifestations of Juvenile Antiphospholipid Syndrome. J Clin Med 2021;10:1240. [PMID: 33802787 DOI: 10.3390/jcm10061240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Vitaliti G, Tabatabaie O, Matin N, Ledda C, Pavone P, Lubrano R, Serra A, Di Mauro P, Cocuzza S, Falsaperla R. The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data. Hum Vaccin Immunother 2015;11:2749-63. [PMID: 26266339 DOI: 10.1080/21645515.2015.1061161] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
22 Markousis-Mavrogenis G, Sfikakis PP, Mavrogeni SI, Tektonidou MG. Combined brain/heart magnetic resonance imaging in antiphospholipid syndrome-two sides of the same coin. Clin Rheumatol 2021;40:2559-68. [PMID: 33196982 DOI: 10.1007/s10067-020-05498-2] [Reference Citation Analysis]
23 Leal Rato M, Bandeira M, Romão VC, Aguiar de Sousa D. Neurologic Manifestations of the Antiphospholipid Syndrome - an Update. Curr Neurol Neurosci Rep 2021;21:41. [PMID: 34125304 DOI: 10.1007/s11910-021-01124-z] [Reference Citation Analysis]
24 Athanasopoulos E, Kalaitzidou I, Vlachaki G, Stefanaki S, Tzagkaraki A, Niotakis G, Tritou I, Ladomenou F. Chorea revealing systemic lupus erythematosus in a 13-year old boy: A case report and short review of the literature. Int Rev Immunol 2018;37:177-82. [PMID: 29595356 DOI: 10.1080/08830185.2018.1452920] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]